Q: Why is AI-guided de novo scaffold generation superior to traditional trial-and-error protein engineering?

A: Traditional methods rely heavily on modifying existing natural proteins, which limits structural diversity. Our machine learning models can generate entirely new non-antibody protein backbones from scratch that perfectly match target geometries, establishing a cutting-edge AI scaffold design service for novel non-antibody binding proteins.